Latest Regulatory Approvals News

St George Mining’s Araxá project now boasts a 111.2Mt rare earths resource after a major post-year-end upgrade, alongside 630,000 tonnes of contained niobium. The 2026 annual report shows a company moving rapidly towards development, but still without an ore reserve, mine design or production decision.

Emperor Energy has moved its Judith Gas Field closer to a targeted April 2027 appraisal well, with the VALARIS 107 rig lined up and regulatory work advancing. But the company’s auditor has highlighted a material uncertainty over its ability to continue as a going concern, with management forecasting a need to raise about $45 million through September 2027.

Finder Energy has shifted decisively from exploration towards development, with its Timor-Leste oil project backed by independent reserves, an acquired FPSO and expanded TIMOR GAP funding. The transition came at a steep cost, however, with a $30.0 million annual loss and Final Investment Decision still ahead.

Key Petroleum reduced its FY2026 loss, but the oil and gas explorer continues to rely on equity funding while awaiting Queensland Government decisions on ATP 920 and ATP 924. An auditor’s unmodified opinion still highlights material uncertainty over the company’s ability to continue as a going concern.

Melbana Energy’s Block 9 project remains on care and maintenance after a partner default and US sanctions on CUPET, despite improved geological understanding from Amistad-2. The company ended FY2026 with $472,504 in cash and warned that additional funding is required to continue.

Sea Forest has reported a sharp lift in SeaFeed revenue during its first full year as an ASX-listed company, but remains loss-making as it funds production and market expansion. The methane-reduction specialist ended FY26 with $27.8 million in cash and term deposits and no borrowings.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

TG Metals has outlined a preliminary A$26.8 million pre-tax NPV for a low-capital heap leach operation at its Van Uden Gold Project in Western Australia. The economics are striking, but the study remains an early-stage assessment reliant on further drilling, approvals, financing and technical work.

Singular Health has signed a non-binding MOU to build and operate a medical imaging repository for Florida Medicaid, with approximately A$3.5 million of potential revenue subject to definitive agreements and delivery. The project could give its 3DICOM platform a state-funded infrastructure reference site, but recurring funding remains unassured.

Navigator Global Investments expects to receive USD40-43 million upfront after New York Life Investment Management agrees to acquire 60% of Invictus Capital Partners. The deal crystallises value from NGI’s 2022 investment while leaving shareholders exposed to earn-outs, distributions and a second sale in 2031.

Heartland Group Holdings (NZX: HGH, ASX: HGH) more than doubled FY2026 net profit as margins widened, asset quality improved and its proposed TSB merger moved towards a shareholder vote. The bank also reported a 16% fall in restated emissions, though much of its climate-risk work remains incomplete or estimate-driven.

Cobalt Blue has secured a US$150,000 contract to deliver key technical work for Glomar Minerals’ planned US polymetallic nodule refinery. The work takes Project Infinity into a formal Preliminary Economic Analysis, although the project remains at an early evaluation stage and its cost estimates carry a wide accuracy range.